Search

for
Search:

Research

5 / 1000+ results

Immune Response Involving the Bulge Region in Addition to Telogen Conversion Contributes to Hair Loss in a Case of Atypical Drug-Induced Hypersensitivity Syndrome

research Immune response involving the bulge region in addition to telogen conversion contributes to hair loss in a case of atypical drug-induced hypersensitivity syndrome

1 citations , October 2013 in “The Journal of Dermatology”

This letter to the editor discusses the immune response related to hair loss in a case of atypical drug-induced hypersensitivity syndrome but reports no new research findings.

research Response to the letter to the editor; Androgenetic alopecia; drug safety and therapeutic strategies

April 2018 in “Expert Opinion on Drug Safety”

Use finasteride over dutasteride for hair loss; consider topical treatments and weigh risks.

research 397 Predictive modeling of drug response and mechanism of action in alopecia areata clinical trials

April 2017 in “The journal of investigative dermatology/Journal of investigative dermatology”

In this study, distinct molecular mechanisms of action were identified for three drugs used in alopecia areata clinical trials, providing insights for precision medicine and treatment selection.

Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm

research Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm

5 citations , February 2024 in “Clinical Pharmacokinetics”

This study found that modeling and simulation effectively informed decision-making and dose selection for ritlecitinib in treating alopecia areata, supporting an accelerated drug development strategy.

Response to the Role of Patient and Drug-Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System

research Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System”

August 2025 in “Journal of Cosmetic Dermatology”

In this study, Gupta et al. observed that pericardial effusions were dose-independently associated with oral minoxidil use for hypertension but not frequently reported during its use for alopecia, suggesting a potential underreporting issue and the need for standardized risk monitoring in alopecia treatment.

View more "drug responses" in research →

Community Join

5 / 1000+ results

community Does drinking coffee with fin affect the bioavailability/absorption of the drug?

2 upvotes 2 years ago

The conversation discusses whether drinking coffee affects the absorption of finasteride. Responses suggest it likely does not.

community How is it possible for someone to be a non responder to ORAL minoxidil?

in Minoxidil 66 upvotes 2 years ago

Some individuals do not respond to oral minoxidil for hair loss, despite it generally working by improving blood flow to hair follicles. Factors like metabolism, drug interactions, and individual variations in the drug's activation may influence its effectiveness.

community Fin/Dut and Metabolism Speeds…

in Finasteride/Dutasteride 8 upvotes 2 years ago

A user speculates that a fast metabolism might affect the effectiveness of dutasteride for hair loss. Another user argues that drug response is unrelated to metabolism speed.

community will pp405 be able to bring my lost temple area back to the game?

10 upvotes 5 months ago

A user is concerned about hair loss in the temple area despite using Minoxidil and finasteride for 10 months and is curious if PP405 can help. Responses indicate uncertainty about PP405's effectiveness, with some optimism about future treatments and AI speeding up drug discovery, but emphasize waiting for clinical trial results.

community 2/3 non response rate to pp405?

10 months ago

PP405 showed 31% regrowth in a short trial, but its effectiveness is debated compared to Minoxidil and Finasteride. Some argue AGA isn't scarring, while others believe it leads to fibrosis, affecting treatment outcomes.

View more "drug responses" in community →

Learn

5 / 801 results

learn Baricitinib

Baricitinib: How did a drug for arthritis end up helping people regrow hair from alopecia areata? Baricitinib helps regrow hair by targeting the autoimmune response in alopecia areata.

learn HMI-115

much-hyped research compound targeting prolactin receptor in scalp

learn Thymosin Beta 4

learn Overview

learn Osteopontin

signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss

View more "drug responses" in learn →

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →